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Abstract
Correct interactions with extracellular matrix are essential to human pluripotent stem cells (hPSC) to maintain their
pluripotent self-renewal capacity during in vitro culture. hPSCs secrete laminin 511/521, one of the most important
functional basement membrane components, and they can be maintained on human laminin 511 and 521 in defined
culture conditions. However, large-scale production of purified or recombinant laminin 511 and 521 is difficult and
expensive. Here we have tested whether a commonly available human choriocarcinoma cell line, JAR, which
produces high quantities of laminins, supports the growth of undifferentiated hPSCs. We were able to maintain
several human pluripotent stem cell lines on decellularized matrix produced by JAR cells using a defined culture
medium. The JAR matrix also supported targeted differentiation of the cells into neuronal and hepatic directions.
Importantly, we were able to derive new human induced pluripotent stem cell (hiPSC) lines on JAR matrix and show
that adhesion of the early hiPSC colonies to JAR matrix is more efficient than to matrigel. In summary, JAR matrix
provides a cost-effective and easy-to-prepare alternative for human pluripotent stem cell culture and differentiation. In
addition, this matrix is ideal for the efficient generation of new hiPSC lines.
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Introduction
Human pluripotent stem cells (hPSC, including both human
embryonic stem cells, hESC and induced pluripotent stem
cells, hiPSC) require either a feeder cell layer or an
extracellular matrix (ECM) coating to support their self-renewal,
suggesting that signals originating from the ECM have a
significant role in hPSC regulation. Consequently, there has
been a growing interest in the extracellular milieu (or niche) of
hPSCs. hPSCs are predominantly cultured on either mouse
embryonic fibroblasts (mEF) or Matrigel, an extracellular matrix
preparation isolated from mouse sarcoma [1-4]. However,
undefined ECM preparations based on various animal
glycoproteins and growth factors are not ideal for hPSC
cultures as they may have unexpected and poorly controllable
biological effects on the cells and furthermore, they cannot be
used in eventual clinical applications.
A specialized extracellular matrix structure, basement
membrane, underlies epithelial and endothelial cells, creating
boundaries between different tissue types in a body [5,6].
Basement membranes consist of diverse protein and
carbohydrate macromolecules that are secreted in cell type
specific manner. Importantly, it has been shown that basement
membranes not only provide mechanical support for tissues but
also maintain tissue homeostasis [7,8]. The most important
group of biologically active signaling proteins in basement
membranes is laminins (lm). Laminins are composed of one
alpha (α), one beta (β) and one gamma (γ) chain that are
twisted together to form either a cruciform or a T-shaped
structure. Currently, at least 15 different combinations (αβγ) of
laminins are known [9-11].
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We have previously shown that laminins-511 (α5β1γ1) and
-111 (α1β1γ1), the two laminin isoforms expressed in early
mouse embryos, are also synthesized by the hPSC cultures
[12]. Our study also demonstrated that hPSCs utilize specific
cell surface receptors when they adhere to the laminin
isoforms. Crucially, we showed that undifferentiated hPSCs
could be maintained on purified human lm-511 in defined
culture medium. Various human recombinant proteins,
including lm-511, vitronectin, fibronectin and their combinations
have been shown to support hPSC maintenance [13-15].
However, large-scale purification or production of biologically
functional human laminins by recombinant technologies is
laborious and expensive. Therefore, here we have developed a
feeder-free, cost-effective and user-friendly hPSC culture
system that is based on the matrix secreted by human
choriocarcinoma cell line JAR, producing high quantities of
lm-511 and -111. Hereafter the matrix is called JAR matrix.
Materials and Methods
Ethics Statement
The generation of human ES lines and their use in these
studies was approved by the Ethics Committee of the Helsinki
University Central Hospital (statement nr. 143/E8/01, on
December 18, 2003).
Donors provided their written informed consent for
participation. The procedure, generation and use of human iPS
cells were approved by the Coordinating Ethics Committee of
the Helsinki and Uusimaa Hospital District (statement nr.
423/13/03/00/08) on April 9, 2009.
The National Animal Experiment Board (http://
www.laaninhallitus.fi/lh/etela/hankkeet/ellapro/home.nsf)
authorized the use of mice in the teratoma assays. The animals
were anesthetized by a mixture of Ketamine and Xylatsine and
Carprofen was used as painkiller during the operation and day
after. The animals were housed under controlled humidity,
temperature, and light regimen and care was consistent with
institutional and National Institute of Health guidelines.
Teratoma growth was followed by palpation, and after seven to
eight weeks, the mice were sacrificed using CO2 and the
teratomas were dissected out.
RNA Isolation and Reverse Transcriptase Reaction
Total RNA was isolated using NucleoSpin RNA XS kit
(Macherey Nagel, Düren, Germany) without on-column DNase
treatment. The DNase treatment (RQ1 RNase-free DNase;
Promega, Madison, WI) was performed separately to confirm
complete elimination of DNA. After the DNase treatment the
samples were purified using NucleoSpin RNA Clean-up kit
(Macherey-Nagel). One µg of total RNA was reverse
transcribed into cDNA by M-MLV reverse transcriptase
(Promega) in 20 µL reverse transcriptase reaction containing
Oligo(dT)15 primers (Promega), the mix of four dNTPs, and
RNAse inhibitor (RiboLock; Fermentas).
RT-PCR
Total RNA was transcribed as described above. RT-PCR
was performed by Maxima Hot Start Taq DNA Polymerase
(Fermentas) as follows: enzyme activation step at 95°C for 4
minutes, followed by 40 cycles of 95°C, 30s/57°C or 60°C 30s/
72°C, 30s and then the final elongation at 72°C for 7 minutes.
The PCR products were separated in 2% agarose gel. The
product for human lm α1 is 89 base pairs (bp), for human lm α2
169 bp, for human lm α3 211 bp, for human lm α4 226 bp, for
human lm α5 97 bp, for human lm β1 247 bp, for human lm β2
298 bp, for human lm β3 201 bp, for human lm γ1 100 bp, for
human lm γ2 197 bp and for human lm γ3 189 bp. Primers are
shown in Table 1. We routinely run all our non-quantitative
PCRs by using a pair of primers for the housekeeping gene,
GAPDH, which recognize the possible genomic DNA
contamination. The product for human GAPDH is 200 bp (+194
bp in case of genomic DNA contamination).
Radioactive Labeling and Immunoprecipitation
The cells were labeled and the samples processed as
described earlier [12]. Briefly, JAR cells were labeled overnight
in culture medium devoid of serum containing 100 µCi 35S-
methionine to label all the proteins produced by the JAR cells.
Then, the medium and matrix produced by JAR cells were
collected and processed as described. Lm α1 and lm α5 were
immunoprecipitated from the culture medium and matrix by
specific monoclonal antibodies (Table 2). Then, the
immunoprecipitated proteins were separated in 5%
polyacrylamide gels. Finally, the gels were dried onto Whatman
filter paper and detected by autoradiography.
JAR Cell Culture
Human choriocarcinoma cells (HTB-144™, American Type
Culture Collection; ATCC) were cultured on tissue culture
dishes in RPMI -1640+GlutaMAX culture medium containing
10% fetal bovine serum (FBS; Promocell, Heidelberg,
Germany). The cells were passaged by trypsin every three to
four days.
Acellular Matrix Preparartion
Approximately 1x104 JAR cells per cm2 were plated on
plastic culture dishes pre-coated with 0.1% gelatin (Sigma-
Aldrich). The cells were allowed to grow for 48 hours, after
which they were washed once with 1X phosphate buffered
saline (PBS) and lysed by 1mM NH3 for 30 minutes at room
temperature (RT). The plates were then carefully washed with
1X PBS for three to four times. Next, the pH of the plates was
balanced by incubating the plates in basal culture medium
(DMEM/F12+GlutaMAX;Life Technologies) at the cell culture
incubator for over night. The plates were either used
immediately or stored at 4°C, in 1X PBS or dried, for up to 4
months.
hPSC Lines
Three pre-established hPSC lines were used in this study.
hESC line FES 29 [16,17] has been derived and thoroughly
characterized in our laboratory. hESC line H9 [18] was
Novel Culture System for Human iPS Cell Derivation
PLOS ONE | www.plosone.org 2 October 2013 | Volume 8 | Issue 10 | e76205
purchased from WiCell institute. The hiPSC line HEL 11.4 [19]
has been generated and thoroughly characterized in our
laboratory. For generation of HEL11.4 hiPSC line, fibroblasts of
a healthy adult donor were induced to pluripotency by Sendai
reprogramming kit (OCT4, SOX2, KLF4, C-MYC; CytoTune;
Life Technologies).
hPSC Culture
The hPSCs were cultured on tissue culture dishes coated
with growth factor reduced Matrigel (diluted 1:200 in DMEM/
F12+GlutaMAX; BD Biosciences, NJ, USA) or on the JAR
matrix, prepared as described above. Defined, serum-free cell
culture medium, StemPro (Life Technologies) was used as
culture medium in all standard cultures. The hPSCs were
passaged by collagenase IV treatment. The cells were
incubated in collagenase IV (1 mG/mL; Invitrogen) for 4
minutes at 37°C and washed once using basal culture medium.
Then, the colonies were detached by cell lifters, triturated into
small clumps and plated on fresh Matrigel or JAR matrix plates
in StemPro culture medium. Prior to culture on JAR matrix, the
hPSCs had been cultured on growth factor reduced Matrigel,
as described above. The early-passage hiPSC were
propagated by manual cutting.
qRT-PCR
For real-time SYBR Green qPCR, total RNA was reverse
transcribed as described above. Each multiplication reaction
run was made in duplicates. The reactions contained SYBR
Green JumpStartTaq ReadyMix (Sigma-Aldrich), 1µL cDNA
template, (RT-reaction), forward and reverse primers
(Oligomer, Helsinki, Finland) and nuclease-free water
(Amresco, Solon, OH) at 20µL. The reactions for the qPCR
were prepared using a Corbett CAS-1200 liquid handling
system and the qPCR was performed using Corbett Rotor-
Gene 6000 (Corbett Life Science, Sydney, Australia) as
follows: enzyme activation step at 95°C for 4 minutes following
40 cycles of 95°C, 20 s/57°C, 20 s/72°C, 20 s, followed by a
melting step. Data was analyzed according to the comparative
∆∆Ct method (Applied Biosystems, User Bulletin 2). As a
reference sample, we used optimized, in-house prepared
positive control mix, which contains cDNA from undifferentiated
hPSCs, spontaneously differentiated hPSCs as well as from
isolated human pancreatic islets. The primer sequences are
listed in Table 1.
Immunocytochemistry
The cells were fixed by 4% paraformaldehyde and washed
several times with 1X PBS. The samples were permeabilized
by 0.5% Triton X-100-PBS for 7 minutes at room temperature
(RT) and washed once with 1X PBS. Then, the samples were
treated with Ultra V Blocking solution (Thermo Scientific,
Waltham, MA, USA) to prevent unspecific binding of
antibodies. Primary antibodies (Table 2) were diluted into 0.1%
Tween-PBS and incubated on the samples over night at 4°C.
Next, the samples were thoroughly washed three times with 1X
PBS. The secondary antibodies (Table 2) were diluted 1:500 in
0.1% Tween-PBS and incubated on the samples for 30
minutes, at RT, in dark. Finally, the samples were washed as
above and mounted in 4',6-diamidino-2-phenylindole (DAPI)
mounting medium (Vector Laboratories, Burlingame, CA, USA).
Table 1. Primers used in qRT-PCR and PCR.
Gene Forward primer Reverse primer Method
Laminin alpha 1 AAGTGTGAAGAATGTGAGGATGGG CACTGAGGACCAAAGACATTTTCCT PCR
Laminin alpha 2 AAATGTACAGAGTGCAGTCGAGGTCA CAGTGGATGCCTTCCACATTCACCTT PCR
Laminin alpha 3 CACTGTGAACGCTGCCAGGAGGGCTA CAGCTACCTCCGAATTTCTGGGGATT PCR
Laminin alpha 4 CACTGTGAAAAGTGTCTGGATGGT CAGGTGCTTCCAATGAGGAAGGGG PCR
Laminin alpha 5 CCCAGCCCCTCTGTACCTC GTTCACCGCCAGCCTCCTC PCR
Laminin beta 1 AACTGTGAGCAGTGCAAGCCGTTT CAACCAAATGGATCTTCACTGCTT PCR
Laminin beta 2 CACTGTGAGCTCTGTCGGCCCTTC CAAGGAGTGCTCCCAGGCACTGTG-3’ PCR
Laminin beta 3 CGGTTGGGTCAGAGTTCCATGC GATCTGCTCCACACGCTTCTCC PCR
Laminin gamma 1 CACAGAGCGGTTGATTGAAA TGGGTCCCCTGTAGATTCTG PCR
Laminin gamma 2 CCGTGCCAATCTTGCTAAAAG GGGTCTTGTCACTGGCATCTG PCR
Laminin gamma 3 CAGGCTCACCAGCCAGACG GCAAGCAGCTCTGACAAGGTC PCR
Sendai GGATCACTAGGTGATATCGAGC ACCAGACAAGAGTTTAAGAGATATGTATC PCR
Oct4 TTGGGCTCGAGAAGGATGTG TCCTCTCGTTGTGCATAGTCG qRT-PCR
Sox2 GCCCTGCAGTACAACTCCAT TGCCCTGCTGCGAGTAGGA qRT-PCR
Nanog CTCAGCCTCCAGCAGATGC TAGATTTCATTCTCTGGTTCTGG qRT-PCR
Sox17 CCGAGTTGAGCAAGATGCTG TGCATGTGCTGCACGCGCA qRT-PCR
Brachyury GCATGATCACCAGCCACTG TTAAGAGCTGTGATCTCCTC qRT-PCR
Sox1 CATGCACCGCTACGACATG AGGGCGACGCGCTCATGTA qRT-PCR
Αlpha-fetoprotein CGCTGCAAACGATGAAGCAAG AATCTGCAATGACAGCCTCAAG qRT-PCR
Albumin GGAAAAGTGGGCAGCAAATGT GGTTCAGGACCACGGATAGA qRT-PCR
doi: 10.1371/journal.pone.0076205.t001
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CELL-IQ Imaging
The early hiPSC colonies were stained for presence
TRA1-60 (Table 2) and taken into Cell-IQ cell imaging system
(ChipMan Technologies, Tampere, Finland) to quantify the
number of TRA1-60 positive colonies in each well.
Flow Cytometry
The hPSCs were detached by TrypLE treatment for 2
minutes and washed in flow cytometry buffer (5% fetal bovine
serum in 1X PBS). Then, the cells were incubated with the
primary antibodies (Table 2) diluted in the flow cytometry buffer
for 1 h on ice. Next, the cells were washed three times with
flow cytometry buffer by centrifuging at 800 rpm for 5 minutes.
The secondary antibodies (Table 2) were diluted in flow
cytometry buffer and incubated on the cells for 30 minutes, on
ice, in dark. The cells were washed as above and ran either
fresh or fixed by paraformaldehyde (PFA) and run later by
FACS Calibur (BD Biosciences) using CellQuestPro software
(BD Biosciences).
Table 2. Antibodies.
Antibody Clone/catalogue Reference Method
SSEA3 MC-631/MAB4303
Solter and Knowles
1979; Peter Andrews,
Sheffield, UK
FACS, ICC
SSEA1 MC-480/MAB4301 Millipore FACS
TRA1-60 TRA1-60/MAB4360 Millipore FACS, ICC,
H-type 1 Ab3355 Abcam FACS
Oct4 Cat. H134 Santa Cruz ICC,
Nanog D73G4/Cat. 4903 Cell SignalingTechnology ICC
Sox17 AF1924 R & D Systems IHC
Tuj1 Tuj1/Cat.MAB1195 R & D Systems ICC, IHC
Vimentin Cat. H84 Santa Cruz IHC
Pax6 Cat. PRB-278P Covance ICC
Albumin 188835/MAB1455 R & D Systems FACS, ICC
Alpha-fetoprotein A0008 DAKO ICC
Alexa Fluor anti-
mouse IgG 488 A21202 Life Technologies ICC
Alexa Fluor anti-
mouse IgM 488 A21042 Life Technologies FACS, ICC
Anti rat IgM
phycoerythrin
G53-238/Cat.
553888 BD Pharmingen FACS
Anti rabbit IgG 594 A21207 Life Technologies ICC
Anti mouse IgM A21046 Life Technologies ICC
Lm α5 4C7 [32] IP
Lm α1 161EB7 [33] IP
Abbreviations: FACS: fluorescence-activated cells sorting/flow cytometry; ICC:
immunocytochemistry; IHC: immunohistochemistry; IP: immunoprecipitation.
doi: 10.1371/journal.pone.0076205.t002
The differentiated, hepatocyte-like cells were detached for 10
to 15 minutes in Trypsin-EDTA (Sigma-Aldrich, Aldrich). Next,
the cells were washed and fixed by 4% PFA for 15 minutes at
RT. Then, the cells were washed once in saponin-containing
flow cytometry buffer (0,1% Saponin and 5% FBS (Promocell,
Heidelberg, Germany) in PBS) prior to 60 min incubation with
primary mouse anti-human albumin antibody (0,5 μg/1x106
cells; R&D Systems). The cells were washed three times with
saponin-containing flow cytometry buffer and incubated for 30
min with the secondary antibody. Then, the cells were washed
and analyzed as above.
Embryoid Bodies
The cells were detached by collagenase IV (1mG/mL),
washed and triturated into small (approximately from 20- to 40-
cell) clumps. The cells were grown on Ultralow attachment
dishes (Corning, Tewksbury, MA, USA), in hPSC culture
medium without basic fibroblast growth factor (20% KnockOut
Serum Replacement, 1% non-essential amino acids, and
0.1mM 2-mercaptoethanol in KnockOut DMEM containing 1X
GlutaMAX; all from Life Technologies) for 10 days. Then, the
embryoid bodies were collected, washed once using 1X PBS
and fixed with 4% PFA for 20 minutes at RT. The fixed samples
were then washed several times by 1X PBS and embedded
into 2% agarose gels, dehydrated and embedded into paraffin.
The sections were then immunostained to detect endodermal
(SOX17), ectodermal (BETA(III)TUBULIN) and mesodermal
(VIMENTIN) derivatives. Shortly, the sections were
deparaffinizated and the primary antibodies (Table 2) were
incubated on the samples for over night at 4°C. Excess
antibodies were removed by washing the samples three times
by 1X PBS. Then, the samples were treated with the secondary
antibodies for 30 minutes, at RT, in the dark. Finally, the
samples were washed as above and mounted into DAPI
mounting medium.
Teratomas
The hPSCs were detached by collagenase IV treatment,
washed and injected into nude mice testis. The tumors were
harvested at 6-8 weeks after injection, fixed by 4% PFA and
processed into paraffin sections. Histology of the tumors was
examined after hematoxylin & eosin staining.
Neuronal Differentiation
The cells were cultured on Matrigel and JAR matrix until
70-80% confluency. The cells were washed twice with 1X PBS
and the neural differentiation medium (1X B27, 1X N2, 2µM
dorsomorphin, 2µM SB431542 in DMEM/F12 containing 1X
GlutaMAX) was changed on the cells (day 0). The pluripotent
status of the cells was confirmed at day 0 by performing a flow
cytometry analysis of the cells using antibodies recognizing
TRA1-60 and SSEA3 epitopes. The neural differentiation
medium was replaced daily for seven days, after which
samples were collected for qPCR and immunocytochemistry
analysis.
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Hepatocyte Differentiation
The cells were cultured on Matrigel and JAR-matrix in
StemPro medium until 80-90% confluency. The cells were then
washed twice in PBS and cultured for 24 h in RPMI-1640 +
GlutaMAX medium supplemented with 2% B27 (both from Life
Technologies), 100 ng/ml Activin A (a gift from Dr Marko
Hyvönen), 3µM CHIR99021 (Stemgent, Cambridge, MA, USA)
and 1 mM sodium butyrate (NaB;Sigma-Aldrich). After 24 h
from the onset of differentiation NaB concentration was
decreased to 0.5 mM and after 48 h the CHIR99021 was
removed from the medium. Then the cells were cultured in this
medium for the following three days with a daily media change.
Differentiation from definitive endoderm (DE)-stage cells into
hepatocyte progenitors was performed essentially as described
by Hay et al in 2008 [20]. Briefly, the DE-cells were washed
with PBS and cultured for five days in KO-DMEM media
supplemented with 20% KO-SR, 1% NEAA, 0.1 mM 2-
mercaptoethanol (all from Life Technologies), 1 mM L-
Glutamine (Omega Scientific, Inc, Tarzana, CA, USA), and 1%
DMSO (Sigma-Aldrich). For hepatocyte maturation, the cells
were washed with PBS and cultured for eight to ten days in
Leibovitz’s L-15 medium (Life Technologies) supplemented
with 8.3% fetal bovine serum (FBS, Promocell), 8.3% Tryptose
phosphate broth (Sigma-Aldrich), 10 µM Hydrocortisone 21-
hemisuccinate (Sigma-Aldrich), 1 mM Insulin (Roche), 2mM
Glutamine (Life Technologies), 25 ng/ml Hepatocyte growth
factor, HGF (Peprotech, Stockholm, Sweden) and 20 ng/ml
Oncostatin M (R&D Systems). Throughout the differentiation
the culture medium was changed daily.
Retroviral hiPSC Inductions
5x104 human foreskin fibroblast (ATCC) cells were plated
into each well of the tissue culture treated six-well plate.
Inductions with retroviral transgene delivery were done using
two bi-cistronic viruses encoding OCT4 and KLF4 in one virus
and SOX2 and c-Myc in the other. Viruses were produced in
293-GPG packaging cell line and pooled media collected from
3 to 5 days after transfection was used to infect the fibroblasts
twice. 3 days after the last infection cells were split and plated
on either JAR matrix or Matrigel coated plates for comparison.
For the pluripotency induction cell culture medium was
changed to hESC medium ((KnockOut™ DMEM;Life
Technologies) supplemented with 20% KnockOut™ serum
replacement, 1% GlutaMAX, 0.1mM-mercaptoethanol, 1%
nonessential amino acids (all from Life Technologies) and 6
ng/ml basic fibroblast growth factor (Sigma-Aldrich))
supplemented with 0.25mM sodium butyrate. Induction
efficiencies were determined by counting TRA1-60 positive
colonies from triplicate inductions at day 14. The hiPSC
colonies were picked to passage 1 at day 14 post inductions.
hiPSC Inductions with Sendai Viruses
Before the inductions, human foreskin fibroblasts (ATCC)
were plated on cell culture dishes (approximately 1X104
cells/cm2). Fibroblasts were induced to form pluripotent cells by
a commercially available Sendai Reprogramming Kit
(CytoTune; Life Technologies) that utilizes the four human
transcription factors, OCT3/4, SOX2, KLF4 and C-MYC. The
infections were performed according to the manufacture’s
instructions. On day 7 post infection, the cells were passaged
on JAR matrix and between days 16 and 19 post infections, the
formed hiPSC colonies were picked on JAR matrix.
Statistical Analysis
Student’s t-test with a 95% confidence level was used to
calculate the significance of differences between cells cultured
on Matrigel vs. JAR matrix in differentiation analysis, hiPSC
induction efficacy and hiPSC colony adhesion at passage 1.
Results
JAR Choriocarcinoma Cells Secrete Laminins -511 and
-111
To investigate the production of laminin subunits by JAR
cells we performed RT-PCR and immunoprecipitation
analyses. Figure 1a shows the mRNA expression of laminin
alpha 1, alpha 3, alpha 5, beta 1, beta 2, beta 3, gamma 1, and
gamma 2 chains. We next confirmed that the JAR cells
synthesized lm-511 and -111 proteins by performing the
metabolic, radioactive labeling of the cells, followed by
immunoprecipitation of the lm α5 and α1 chains from the JAR
cell culture medium by using monoclonal antibodies (Table 2).
The results demonstrate that JAR cells abundantly secrete
lm-511 and -111 isoforms into culture medium (Figure 1b; on
the left). In addition, we confirmed that JAR cells deposit
lm-511 into ECM (Figure 1b; on the right).
The JAR Cell Culture Matrix Supports Long-Term
Maintenance and Pluripotency of hPSCs
We cultured one hESC line, FES29 [16] and one hiPSC line,
HEL11.4 [19] in parallel for 15 passages and a second hESC
line, H9 [18] for 12 passages on both JAR matrix and growth
factor reduced Matrigel in a defined, serum-free culture
medium, StemPro. At the end of culture, the cells were
characterized and their differentiation capacity was evaluated
with several methods. Figure 2 shows characterization of the
FES29 and HEL11.4 cells cultured on either JAR matrix or
Matrigel, for 15 passages. The cell lines maintained high
expression levels of the pluripotency marker genes OCT4,
SOX2 and NANOG on both matrices (Figure 2a). The
expression level of some differentiation-related genes, such as
SOX17 and BRACHYURY tended to slightly increase during
culture but the changes were minimal on both matrices and
even smaller on JAR matrix as compared to Matrigel (Figure
2a).
To quantify the proportion of the undifferentiated hPSCs we
performed a series of cell surface marker analyses with flow
cytometry on the cells cultured on JAR matrix or Matrigel.
Figure 2b shows that the hPSCs maintained their
undifferentiated state equally well on both matrices. At passage
15, both cell lines had more than 85% SSEA3 positive cells on
JAR matrix and Matrigel. At the same time, 72% (FES29) and
85% (HEL11.4) of the cells were TRA1-60 positive on JAR
matrix and 96% (FES29) and 85% (HEL11.4) of the cells were
TRA1-60 positive on Matrigel (Figure 2b). We also analyzed
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the presence of the H type 1 antigen [19,21] on the hPSCs and
found that it was present on approximately 90% of the cells,
regardless of the cell line, passage or culture conditions.
SSEA1 antigen, which refers to differentiation of the hPSCs,
was present on 7% (FES29) and 11% (HEL11.4) of the cells
that had been cultured on JAR matrix for 15 passages and on
14% (FES29) and 17% (HEL11.4) of the cells that had been
cultured on Matrigel. figure S1 represents the flow cytometry
histograms of the FES29 and HEL11.4 cells cultured on JAR
matrix for 15 passages. Both of the cell lines maintained typical
undifferentiated morphology and showed nuclear expression of
the transcription factors POU5F1 (also known as OCT4) and
NANOG and also showed presence of TRA1-60 antigen after
being cultured on JAR matrix or Matrigel (Figure 2c shows the
results for the hiPSC line HEL 11.4.).
The chromosomal integrity of the cells was studied by the
novel method, KaryoLite [22]. The assay measures DNA copy
numbers at the chromosome arm resolution utilizing bacterial
artificial chromosome (BAC) probes immobilized onto color-
encoded polystyrene microspheres distinguishable by
fluorometry. The probes are targeted to proximal and terminal
regions of each chromosome arm of metacentric and sub-
metacentric chromosomes and q-arms of acrocentric
chromosomes. As previous studies have indicated that the
most common karyotype abnormalities in hESCs involve gains
of whole chromosomes or telomeric regions of chromosomes, it
is expected that the probes included in the KaryoLite™ BoBs™
cover the frequent and recurrent abnormalities [23]. The
method is superior to the conventional karyotyping covering the
genomic DNA from all collected cells instead of representative
metaphases. The H9 cells were cultured for 12 passages on
the JAR culture matrix and Matrigel and analyzed for karyotype
changes. At the time of collecting the samples, we also
performed flow cytometry analysis on the cells to confirm that
the cells were positive for the pluripotency markers SSEA3 and
TRA1-60 (data not shown). The H9 cells did not show changes
in the karyotype after 12-passage culture on JAR matrix or
Matrigel (Figure S2). However, since the karyotyping method
does not recognize inversions, translocations or low-level
mosaicism, we cannot rule out the possibility of such changes
in the cells.
Figure 1.  Expression and synthesis of laminins by JAR cells.  A) JAR choriocarcinoma cells transcribe lm α1, lm α3, lm α5, lm
β1, lm β2, lm β, lm γ2, and lm γ1 chains as shown by RT-PCR. As a reference sample, we used optimized, in-house prepared
positive control mix, which contains cDNA from undifferentiated hPSCs, spontaneously differentiated hPSCs as well as from
isolated human pancreatic islets. B) JAR choriocarcinoma cells were metabolically labeled with 35S and the cell culture supernatant
and matrix deposited by JAR cells were immunoprecipitated using antibodies, which specifically recognize the human lm α1 (400
kDa) and lm α5 (350-380 kDa) chains. The cells showed abundant lm-511 and -111 synthesis.
doi: 10.1371/journal.pone.0076205.g001
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Figure 2.  JAR matrix maintains hPSCs undifferentiated and pluripotent.  A) Two hPSC lines, FES29 and HEL11.4, were
cultured on JAR matrix or Matrigel for 15 passages and characterized in the beginning (p0), at p5 and at p15. Expression of genes
typical for undifferentiated hPSCs (OCT4, SOX2, NANOG) and early differentiation markers (SOX1, SOX17 and BRACHYURY)
were analyzed by qPCR. Each data point represents the pooled sample from five replicate plates per cell line.
B) The hPSC lines were analyzed by flow cytometry in the beginning (p0), at p5 and at p15. The levels of SSEA3, TRA1-60 and H1
type antigen were high throughout the culture period, while the level of SSEA1 remained low, suggesting that pluripotent hPSCs
were maintained on JAR matrix equally well as on Matrigel. Each time point represents the pooled sample from five replicate plates
per cell line.
C) Morphology of the hiPSC line HEL11.4 on JAR matrix and on Matrigel. Phase contrast micrographs and immunofluorescent
staining of the hiPSC line HEL11.4 with antibodies recognizing OCT4, Tra1-60 and NANOG, after culture for 15 passages on JAR
matrix. Scale bars: 500 µm for the upper phase contrast image of HEL11.4. on JAR matrix, others 100 µm.
D) hPSCs formed typical embryoid bodies after 15-passage culture on JAR matrix. Presence of endodermal (SOX17), ectodermal
(BETA(III)TUBULIN/TUJ1) and mesodermal (VIMENTIN) derivatives was detected by immunofluorescence in hiPSC line HEL 11.4.
Scale bar 100 µm.
E) Mature derivatives of all germ layers; neuroectoderm, endoderm and mesoderm in a teratoma obtained from the hiPSC line
HEL11.4 after culture on JAR matrix for 15 passages. Objective magnification 40X.
doi: 10.1371/journal.pone.0076205.g002
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To investigate whether the hPSCs cultured on JAR culture
matrix were able to differentiate to endoderm, ectoderm and
mesoderm, we performed in vitro differentiation by inducing
embryoid body formation on ultra low-adherent plates. The
hPSCs formed embryoid bodies that contained endodermal
(SOX17), mesodermal (VIMENTIN) and ectodermal
(BETA(III)TUBULIN/TUJ1) structures (Figure 2d demonstrates
the results for HEL11.4. and Figure S3 shows the results for
FES29). To find out whether the hPSCs grown on JAR matrix
are able to differentiate in vivo, we transplanted the hPSCs
cultured on JAR matrix into testes of nude mice. Indeed, the
transplanted cells formed multiform teratomas containing
mature tissues from all the germ layer lineages, as shown for
HEL11.4 in Figure 2e. The results for FES29 are shown in
Figure S3.
JAR Matrix Allows hPSC Differentiation into Neuronal
and Hepatocyte-like Cells
We next tested two targeted differentiation protocols with the
cells cultured on JAR matrix. We induced differentiation
towards neuronal cell fate by using a simple protocol based on
two small molecules, Dorsomorphin (also known as Compound
C) and SB431542 [24]. During the course of seven-day
differentiation, the H9 cells turned into neuronal cells on JAR
matrix and on Matrigel, as shown in Figure 3. The qPCR
results show pronounced down-regulation of POU5F1,
whereas the relative expression level of SOX1 and PAX6 had
increased (Figure 3a). The morphology of the H9 cells on JAR
matrix prior to onset of differentiation is shown in Figure 3b (the
upper panel). After a 7-day differentiation,
immunocytochemistry staining for PAX6 and
BETA(III)TUBULIN showed abundant neuronal commitment on
both culture matrices (Figure 3b; lower panels). These results
indicate that most of the cells had differentiated into neuronal
lineage (Figure 3).
JAR Matrix Supports hPSC Differentiation into
Hepatocyte-like Cells
The other differentiation protocol, based on the results by
Hay and coworkers directs hPSCs to hepatocyte-like cells [20].
The hPSCs were first induced to undergo definitive endoderm
differentiation for 5 days, followed by hepatocyte differentiation.
There were no significant differences between the definitive
endoderm cells differentiated on JAR matrix and on Matrigel
(data not shown). After 18 days of differentiation, prominent
hepatocyte differentiation had taken place on both culture
matrices (Figure 4). ALBUMIN and α-FETOPROTEIN
expression levels increased throughout the differentiation, as
shown by qPCR (Figure 4a). The α-FETOPROTEIN expression
increased 2700-fold on Matrigel and 5200-fold on JAR matrix
(p=0.0154) and the relative ALBUMIN expression level of the
hepatocyte-like cells differentiated on JAR matrix was 7400-
fold, while on Matrigel the relative albumin expression level
was 8500-fold (Figure 4a). The difference in albumin
expression level was not statistically significant. The typical
morphology of the differentiated cells and
immunocytochemistry staining for albumin and α-fetoprotein
are shown for HEL11.4. in figure 4b. The flow cytometry results
confirmed prominent differentiation into hepatocyte-like cell
population (Figure 4c). These data show that the JAR culture
matrix can be used to differentiate hPSCs into
neuroectodermal and endodermal target tissues.
Effective Derivation of hiPSC Lines on JAR Matrix
Finally, we tested whether JAR matrix could be used for
hiPSC induction and early passaging of the newly formed
colonies. Human foreskin fibroblasts (5x104 cells/well) were
induced by retroviruses containing OCT4, KLF4, SOX2, and c-
myc. Three days after induction the cells were split on either
JAR matrix or Matrigel. Morphology of the forming iPS cell
colonies was examined daily. There were fewer small ‘satellite’
colonies on JAR matrix than on Matrigel (Figure 5a). The cells
were fixed at day 14 post induction and stained for TRA1-60.
No difference between the induction efficacy on JAR matrix
and Matrigel was observed (Figure 5b and Figure S4). To study
the attachment and survival of newly formed hiPSC colonies,
we picked twelve colonies from three separate inductions at
day 14 and plated them on either JAR matrix or Matrigel. We
then counted how many colonies adhered and formed self-
renewing clones. All the colonies plated on JAR matrix adhered
and formed morphologically typical hiPSC lines, whereas only
83% of the colonies plated on Matrigel adhered (p=0.025;
Student’s t-test) (Figure 5c). We evaluated the morphology of
the clones on JAR matrix and Matrigel and counted how many
of the adhered clones maintained undifferentiated morphology.
There was no statistically significant difference between the
matrices in the sustainability of the early hiPSC clones.
Next, we established new hiPSC lines on JAR matrix by
using non-integrating Sendai viruses. Two to three weeks after
transductions individual newly formed hiPSC colonies were
picked on JAR matrix (passage 1). Two hiPSC lines were
cultured on JAR matrix for 15 passages and characterized
between passages 12 and 15. The new hiPSC lines met all of
the standard criteria for pluripotent cells. They expressed high
levels of POU5F1, SOX2 and NANOG but were free from
transgene expression, as measured by RT-PCR (Figure 6a).
They were positive for TRA1-60 and NANOG (Figure 6b).
Undifferentiated cells of the hiPSC2 line formed well-
differentiated teratomas containing tissue from mesodermal,
endodermal and ectodermal lineages when transplanted into
nude mice (Figure 6c). Their karyotypes were normal by the
KaryoLite method (Figure S5).
Discussion
There has been a growing interest in developing defined,
serum-free culture conditions for hPSCs, based on distinct
basement membrane protein coatings and defined culture
media [12-15,25-27]. However, a major disadvantage in the
use of the purified and/or recombinant basement membrane
proteins is their limited availability and high cost. Therefore, by
utilizing a commercially available human cell line that, among
other ECM components, produces high quantities of laminins
511 and -111, we have established an economical and easy-to-
prepare culture matrix, which supports the growth of
undifferentiated hPSCs and development of early hiPSC
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Figure 3.  JAR matrix allows hPSC differentiation to neuronal lineages.  A) The qPCR results show that the expression level of
OCT4 declined during directed neuronal differentiation on JAR matrix and Matrigel while the expression levels of SOX1 and PAX6
increased. Expression level is relative to an in-house prepared positive control mix, which contains cDNA from undifferentiated and
differentiated hPSCs and human pancreatic islets. Data represent the mean (±SD) of results from two independent experiments with
the hPSC line H9.
B) Phase contrast images of the H9 cells cultured on JAR matrix prior to onset of differentiation (upper panel). Scale bars 500 µm
(left) and 100 µm, (right). After a 7-day differentiation, the majority of the hPSCs had differentiated to PAX6 and/or
BETA(III)TUBULIN positive cells. The data represents the hPSC line H9, cultured for 5 passages on JAR matrix before the
differentiation.
doi: 10.1371/journal.pone.0076205.g003
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clones. We were able to maintain all the tested hPSC lines on
the JAR culture matrix for at least 15 passages using a defined,
serum-free cell culture medium. The hPSC lines maintained
high expression levels of the typical hPSC marker genes and
they were able to differentiate into all germ line derivatives
when induced. These data show that the JAR culture system
allows the maintenance and expansion of the undifferentiated
cells without restricting their differentiation capacity. The
hPSCs cultured on JAR matrix formed very well differentiated,
mature teratomas and differentiated spontaneously in embryoid
body assay. In addition, we were able to differentiate the
hPSCs cultured on JAR matrix to neural as well as to
hepatocyte-like cells, demonstrating that the matrix can be
utilized in targeted differentiation of hPSCs.
Novel hiPSC induction methods are developed continuously.
However, a standard practice is still to pick the newly formed
colonies on a feeder cell layer. We were able to generate new
hiPSC lines on JAR culture matrix. Importantly, while there was
no difference in hiPSC induction efficacy, the newly generated
hiPSCs adhered better on JAR matrix than on Matrigel.
Enhanced adhesion of the early hiPSCs may serve to increase
the quality of the established clones by reducing partially
reprogrammed and aberrant clones.
Figure 4.  JAR matrix supports hPSC differentiation to hepatocyte like cells.  A) qRT-PCR analysis of the expression levels of
hepatocyte differentiation markers, AFP and ALBUMIN, during differentiation. Data represent the mean (±SEM) of three
independent experiments on H9 and HEL11.4 cells.
B) The morphology (upper panel) and immunocytochemistry for ALBUMIN and AFP (lower panel) of the HEL11.4 cells after
differentiation. Scale bars 100 µm.
C) Quantitative flow cytometry analysis of the cells after differentiation to hepatocyte like cells on JAR matrix or Matrigel. The results
are representative for three independent experiments.
doi: 10.1371/journal.pone.0076205.g004
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Fukusumi et al. recently reported derivation of hiPSCs on
pericellular matrix of decidua derived mesenchymal cells [28].
They showed that the decidua derived mesenchymal cell
matrix supported derivation and long-term culture of hiPSCs.
However, they did not characterize the extracellular matrix
produced by the mesenchymal cells. In addition, the hPSCs
showed some differentiation after long-term culture on decidua
derived mesenchymal cell matrix when cultured in defined
culture medium, StemPro, but not when cultured in mEF-
conditioned medium. Our recent data suggests that mEFs
produce lm-511 and it is known that lm-511 synthesis
correlates with the ability of human fibroblasts to support hPSC
maintenance [29]. Therefore, we suggest that the presence of
lm-511 in JAR matrix supports the self-renewal of hPSCs.
hPSCs are prone to apoptosis when dissociated for example
at passaging and therefore, Rho associated protein kinase
(ROCK) inhibitors are widely used [30]. Based on our results,
ROCK inhibitors are not needed to maintain hPSC viability on
JAR matrix. Similar results were recently reported for the
laminin E8 fragment, comprising the integrin-binding C-terminal
domains of either lm-511 or -332 [31]. Hence, we suggest that
JAR matrix supports the adhesion and self-renewal of human
Figure 5.  JAR matrix supports adhesion of the early hiPSC colonies.  A) Formation of the hiPSC colonies on JAR matrix (left
panel) and Matrigel (right panel) at day 5, 7, 9, 11 and 13 after retroviral transduction. Objective magnification 4X.
B) The hiPSC colonies from three independent retroviral inductions on JAR matrix and Matrigel were stained for TRA1-60 on day 14
and imaged by the Cell-IQ imaging system. There was no difference in the number of colonies. N=3.
C) Twelve clones from three independent inductions were picked and plated either on JAR matrix or Matrigel. The clones adhered
significantly better on JAR matrix (left). There was no significant difference on early differentiation of the clones on JAR matrix and
Matrigel (right). N=3.
doi: 10.1371/journal.pone.0076205.g005
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Figure 6.  Characterization of new hiPSC lines generated on JAR-matrix.  A) Human foreskin fibroblasts were induced to
pluripotency by the Sendai virus reprogramming kit. Both hiPSC lines showed endogenous expression of OCT4, SOX2 and NANOG
but were free from sendai virus replicon when analyzed at passage 12.
B) The hiPSC lines generated on JAR matrix were stained for presence of TRA1-60 and NANOG. Both of the hiPSC lines were
positive for the pluripotency markers. Scale bar 100 µm.
C) Undifferentiated hiPSC2 cells were transplanted into testes of nude mouse. The hiPSC 2 cells had formed well-matured
teratoma, which contained endodermal, mesodermal and neuroectodermal derivatives.
doi: 10.1371/journal.pone.0076205.g006
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pluripotent stem cells by providing an ideal ECM milieu, rich in
physiologically relevant laminin isoforms. In conclusion, our
results indicate that in addition to supporting the self-renewal of
pre-existing hPSC lines, JAR culture matrix is ideal for the
support of newly derived hiPSC colonies.
Supporting Information
Figure S1.  Representative results from the flow cytometry
analysis. The hPSC lines HEL11.4 and FES29 were analyzed
for presence of stem cell markers TRA1-60, SSEA3 and H type
1 antigen and differentiation marker SSEA1, after 15-passage
culture on JAR matrix. White filling indicates the negative
control and black filling indicates staining with the primary
antibody, followed with the secondary antibody.
(TIF)
Figure S2.  hESC line H9 retained a normal karyotype after
cultured on either JAR matrix or Matrigel for 12 passages.
In the figure is the representative data from the karyotypic
analysis of the H9 cells grown on either JAR matrix or Matrigel.
The red and blue lines indicate the normalized chromosomal
signal ratios against the female (red) and male (blue)
references with normal genotype as calculated by BoBs
software. For the normal chromosomes the signal ratios should
reside inside the reference area around value 1, whereas in the
case of chromosomal abbreviation both signal ratios should
exceed the calculated threshold values and locate clearly
outside the calculated reference area.
(TIF)
Figure S3.  JAR matrix supports pluripotency of hPSCs. A)
The phase contrast image of the hPSC line FES29 cultured on
JAR matrix for 15 passages.
B) Undifferentiated cells of the hPSC line FES29 were
transplanted into nude mouse for teratoma formation after 15-
passage culture on JAR matrix. The cells formed derivatives of
mesoderm (VIMENTIN), ectoderm (BETA(III)TUBULIN/TUJ1)
and endoderm (SOX17), indicating that the cells had
maintained pluripotent.
C) The hPSC line FES29 formed embryoid bodies with
derivatives from all germ layers: endoderm (FOXA2),
mesoderm (BRACHYURY), and ectoderm (BETA(III)TUBULIN/
TUJ1) after 15-passage culture on JAR matrix. Scale bars
100µm.
(TIF)
Figure S4.  The JAR matrix supports human iPSC
inductions. Three independent, retroviral hiPSC inductions
were performed on JAR matrix and Matrigel. Induction
efficiencies were determined by counting the alkaline
phosphatase positive colonies at day 14. The iPSC induction
efficiency on JAR matrix was comparable to that on Matrigel.
Data represent the mean (±SEM) of three independent
inductions.
(TIF)
Figure S5.  Two new hiPSC lines generated and cultured
on JAR matrix maintained normal karyotypes. hiPSC1 and
hiPSC2 lines were generated on the JAR matrix. Both of the
new hiPSC lines showed normal karyotype after cultured for 12
passages on JAR matrix. The red and blue lines indicate the
normalized chromosomal signal ratios against the female (red)
and male (blue) references with normal genotype as calculated
by BoBs software. For the normal chromosomes the signal
ratios should reside inside the reference area around value 1,
whereas in the case of chromosomal abbreviation both signal
ratios should exceed the calculated threshold values and locate
clearly outside the calculated reference area.
(TIF)
methods S1.  Supplementary Materials and Methods.
(PDF)
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